呼吸系統疾病

互動

閱讀原始引言

我們向藥品福利諮詢委員會 [PBAC] 提供公眾意見，就氣喘相關藥物（包括部分疫苗）的給付事宜進行建議。

We provide public comment to the Pharmaceutical Benefits Advisory Committee for the reimbursement of medicines relating to asthma, including some vaccines. We write and support submissions to the Therapeutic Goods Administration for changes to medicines. Asthma Australia will lobby government if a change that is made is not in the best interest of people with asthma.

互動

閱讀原始引言

患者群體證據提交至加拿大藥物局（CADTH [加拿大藥物與健康技術局]、INESSS [國家健康與社會服務卓越研究院] 及 BC [不列顛哥倫比亞省] 藥物保險計畫）。

Patient Group Evidence submissions to Canada's Drug Agency (CADTH), INESSS and BC Pharmacare.

行動與倡議

閱讀原始引言

我們正積極推動修訂或廢除第99號備忘錄〔第99號備忘錄是義大利藥品管理局（AIFA）針對慢性阻塞性肺病（COPD）維持療法的給付指引，規範吸入器的處方開立，透過肺量計檢查確保適當診斷，並詳細說明哪些治療可由一般科醫師啟動或續開〕。我們也正積極推動呼吸道融合病毒（RSV）疫苗接種。

Ci stiamo battendo per la modifica/abolizione della nota 99. Ci stiamo battendo per la vaccinazione per VRS.

行動與倡議

閱讀原始引言

…與英國國會議員合作，推動提升肺纖維化的認知度、爭取更多疾病治療資金，以及為患者及其家屬、照護者和朋友提供更完善的支援。

Work in conjunction with national and international organisations and charities. Work with government members of parliament campaigning for better recognition of pulmonary fibrosis, additional funding for the treatment of the disease, greater support for the patients with the disease along with their families, carers and friends.